According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
primary biliary cirrhosis, which is considered to be an autoimmune disease.
[LDN] reports that all patients with autoimmune processes whom the late
Dr. Bihari [Bihari2003] treated using LDN "have experienced a halt in progression of their
illness.
In many patients there was a marked remission in signs and symptoms of the disease."
Dr. Bihari suggests a 50% to 70% overall response rate [Bihari2003].
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of Primary Biliary Cirrhosis with LDN.
Please see What is Low Dose Naltrexone?
for more information.
[McCulley2018, pg 28] reports that primary biliary cirrhosis is a localized
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of primary biliary cirrhosis
with Immune System Balancing.
Please see What is Immune System Balancing?
for more information.